Some CA Pharmacies Now Including Info on Dangerous Interactions with THC and CBD

The use of marijuana can, at times, be confusing for the general public because it is legal for adults in California. The San Diego Marijuana Prevention Initiative has joined with 17 local pharmacies in San Diego County to include information about possible drug interactions with marijuana use when customers pick up their prescriptions. Information, provided both in English and Spanish, will be provided, as well as a referral to to check for dangerous drug interactions between THC, CBD and their own prescription medications.

Common types of drugs that can have dangerous interactions with marijuana include:
Sedatives — such as Ambien, Lunesta and Benadryl
Anti-anxiety medications — such as Xanax, Valium and Librium
Antidepressants — such as Zoloft, Prozac and Lexapro
Pain medications — such as codeine, Percocet and Vicodin
Anticonvulsants (seizure medications) — such as Tegretol, Topamax and Depakene
Anticoagulants (blood thinners) — such as Coumadin, Plavix and heparin

To read the full article, click here:

For more information about the Marijuana Prevention Initiative, click here:

For more information on the International Academy on the Science and Impact of Cannabis, and to join, please visit

Visit the IASIC Library here ( The IASIC Library is intended as a user-friendly reference of the published medical literature.

Like this article?

Share on facebook
Share on Facebook
Share on twitter
Share on Twitter
Share on linkedin
Share on Linkdin
Share on pinterest
Share on Pinterest

Leave a comment

Related Posts

What is THCP?

THCP, which is short for tetrahydrocannabiphorol and scientifically known as (-)-Trans-Δ9-tetrahydrocannabiphorol, is a natural cannabinoid and analog of THC present in varieties of cannabis. It’s thought to be 33 times more active at cannabinoid 1 (CB1) receptors than THC, causing an intense and intoxicating euphoric high. THCP’s legality is stuck between conflicting federal legislation. It’s not

Cannabis Legalization and Detection of Tetrahydrocannabinol (THC) in Injured Drivers

A recent study funded by the Canadian Institutes of Health Research found that after cannabis legalization, the prevalence of moderately injured drivers with a THC level of at least 2 ng per milliliter in participating British Columbia trauma centers more than doubled. The increase was largest among older drivers and male drivers. During the study

Cannabis Contaminants Limit Pharmacological Use of Cannabidiol

For nearly a century, Cannabis has been stigmatized and criminalized across the globe, but in recent years, there has been a growing interest in Cannabis due to the therapeutic potential of phytocannabinoids. With this emerging interest in Cannabis, concerns have arisen about the possible contaminations of hemp with pesticides, heavy metals, microbial pathogens, and carcinogenic compounds during the cultivation, manufacturing,

Scroll to Top